Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Recruiting · NCT06417502 · Observational (researchers observe without assigning treatment) · Lead sponsor: Peking Union Medical College Hospital
View the official record on ClinicalTrials.gov →What this trial is about
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.
Who can take part
Age range
Up to 18 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \<= 18 years old
- Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity)
- Diagnosed and Treated in China
Exclusion criteria
- Disagreement of involving in this study by the patient or his/her family.
Where it is running
9 locations listed.
- Peking Union Medical College Hospital - Beijing, Beijing Municipality, China
- Beijing Children's Hospital, Capital Medical University - Beijing, Beijing Municipality, China
- Third Hospital of Peking University - Beijing, Beijing Municipality, China
- Chidren's Hospital of Chongqing Medical University - Chongqing, Chongqing Municipality, China
- Shenzhen Children's Hospital - Shenzhen, Guangdong, China
- The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI) - Shenzhen, Guangdong, China
- The Second Xiangya Hospital of Central South University - Changsha, Hunan, China
- Children's Hospital of Nanjing Medical University - Nanjing, Jiangsu, China
- Children's Hospital of Zhejiang University School of Medicine - Hangzhou, Zhejiang, China